Circio Holding ASA (OSL:CRNA) Short Percentage of Float


OSL:CRNA Circio Holding ASA OSL:CRNA
26 GF Score
Price kr7.34
! 3 Warning Signs
View Full Analysis

What is Circio Holding ASA Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OSL:CRNA vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Circio Holding ASA's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Circio Holding ASA Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circio Holding ASA's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Circio Holding ASA's Short Percentage of Float falls into.


OSL:CRNA
26GF Score
Circio Holding ASA OSL:CRNA
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Circio Holding ASA Business Description

Other Exchanges 0RIS:UKTA50:Germany
Address c/o Mesh Community AS, Tordenskiolds Gate 2, Oslo, NOR, 0160
Circio Holding ASA is a biotechnology company developing circular RNA expression technology for gene and cell therapy applications. It has developed a circular RNA (circRNA) vector expression platform known as circVec, which is based on modular genetic constructs designed for circRNA production within target cells. The platform is being developed for applications including genetic medicine, cell therapy, and chronic disease treatment. The company's activities also include the development of RNA, DNA, and viral therapeutic technologies related to gene expression and protein production.
26GF Score

Get the complete analysis for OSL:CRNA

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr7.34
Price